Published in Clin Exp Metastasis on September 01, 1997
Purinergic signalling and cancer. Purinergic Signal (2013) 1.18
Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br J Cancer (2001) 1.15
Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model. Radiology (2011) 0.83
Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases. Br J Cancer (2001) 0.83
Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model. J Appl Physiol (1985) (2013) 0.82
Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers. Clin Exp Metastasis (2003) 0.78
Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography. World J Gastroenterol (2007) 0.77
Is it relevant that intra-arterial chemotherapy may be effective for advanced pancreatic cancer? World J Gastroenterol (2007) 0.76
Angiotensin II increases gene expression after selective intra-arterial adenovirus delivery in a rabbit model assessed using in vivo SSTR2-based reporter imaging. EJNMMI Res (2016) 0.75
Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer (1985) 1.84
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett (1983) 1.68
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology (1996) 1.66
Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies. Acta Physiol Scand Suppl (1981) 1.64
Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg (1990) 1.07
Calcitonin gene-related peptide immunoreactivity in the biliary pathway and liver of the guinea-pig: distribution and colocalization with substance P. Cell Tissue Res (1988) 1.02
Regional differences in endothelium-dependent relaxation in the rat: contribution of nitric oxide and nitric oxide-independent mechanisms. Acta Physiol Scand (1995) 1.01
Localization of adrenergic and neuropeptide tyrosine-containing nerves in the mammalian liver. Hepatology (1989) 0.98
Increased capillary flow in intrahepatic tumors due to alpha-adrenergic effects of catecholamines. Cancer (1988) 0.98
Effects of catecholamines on cardiovascular response and blood flow distribution to normal tissue and liver tumors in rats. Cancer Res (1980) 0.94
Integration of factors controlling vascular tone. Overview. Anesthesiology (1993) 0.93
Characteristics of microcirculation in experimental tumours. Bibl Anat (1969) 0.93
[The effect of noradrenaline, adrenaline, isoproterenol and adenosine on the blood flow in the liver and in the splanchnic area in dogs]. Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 0.93
Facilitation by partial hepatectomy of tumor growth within the rat liver following intraportal injection of syngeneic tumor cells. Clin Exp Metastasis (1991) 0.91
Pattern of spread of bloodborne tumour. Br J Surg (1986) 0.91
Co-localization of neuropeptide tyrosine (NPY) and its C-terminal flanking peptide (C-PON). Peptides (1986) 0.90
Ultrastructural localization of somatostatin- and substance P-immunoreactive nerve fibers in the feline liver. Gastroenterology (1992) 0.84
Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat. Hepatology (1995) 0.84
Distribution, possible origins and fine structure of neuropeptide Y-containing nerve fibers in the rat liver. Brain Res (1989) 0.83
Prevention of neuropathy in the pyloric sphincter of streptozotocin-diabetic rats by gangliosides. Gastroenterology (1993) 0.82
The absence of autonomic perivascular nerves in human colorectal liver metastases. Br J Cancer (1996) 0.82
Distribution of substance P and vasoactive intestinal peptide in the human liver: light and electron immunoperoxidase methods of observation. Am J Gastroenterol (1991) 0.82
Light and electron microscopy of neuropeptide Y-containing nerves in human liver, gallbladder, and pancreas. Gastroenterology (1991) 0.80
Electron microscope study on the innervation of guinea pig liver--proposal of sensory nerve terminals in the hepatic parenchyme. Arch Histol Jpn (1984) 0.78
Treatment options for colorectal liver metastases. Postgrad Med J (1992) 0.77
Hepatic microvascular regulatory mechanisms. II. Cholinergic mechanisms. Hepatology (1982) 0.75
Receptors for purines and pyrimidines. Pharmacol Rev (1998) 13.92
Purinergic nerves. Pharmacol Rev (1972) 12.05
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol (1985) 9.20
Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol (1970) 8.20
Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell (1997) 7.59
The inhibitory innervation of the taenia of the guinea-pig caecum. J Physiol (1966) 5.53
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
A P2X purinoceptor expressed by a subset of sensory neurons. Nature (1995) 4.86
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature (2000) 4.53
Transmission from intramural inhibitory nerves to the smooth muscle of the guinea-pig taenia coli. J Physiol (1966) 4.22
Apamin blocks certain neurotransmitter-induced increases in potassium permeability. Nature (1979) 3.93
Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther (1994) 3.93
The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol (1982) 3.52
Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol Clin Exp Res (2000) 3.42
Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett (1993) 3.38
Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol (1990) 3.34
ATP as a co-transmitter in rat tail artery. Eur J Pharmacol (1984) 3.28
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol (1984) 3.24
P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y-but not the P2x-purinoceptor. Br J Pharmacol (1987) 3.15
Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol (1972) 2.93
Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol (1991) 2.88
Review lecture. Neurotransmitters and trophic factors in the autonomic nervous system. J Physiol (1981) 2.85
Dynamic actin-based epithelial adhesion and cell matching during Drosophila dorsal closure. Curr Biol (2000) 2.78
Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet (1998) 2.70
A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg (1985) 2.66
Purinergic innervation of the guinea-pig urinary bladder. Br J Pharmacol (1978) 2.61
G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol Sci (1994) 2.57
Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. Neuron (1999) 2.50
Transmission from perivascular inhibitory nerves to the smooth muscle of the guinea-pig taenia coli. J Physiol (1966) 2.48
P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci (2001) 2.41
Evidence that ATP acts as a co-transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas deferens. Eur J Pharmacol (1983) 2.40
Purinergic signalling: ATP release. Neurochem Res (2001) 2.33
Superior mesenteric artery syndrome. Postgrad Med J (1997) 2.22
Assessment of morbidity from complete axillary dissection. Br J Cancer (1992) 2.20
Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg (2003) 2.13
Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci (1997) 2.09
Evidence that prostaglandin is responsible for the 'rebound contraction' following stimulation of non-adrenergic, non-cholinergic ('purinergic') inhibitory nerves. Eur J Pharmacol (1975) 2.09
Life events and breast cancer prognosis. BMJ (1992) 2.03
Evidence for purinergic innervation of the anococcygeus muscle. Br J Pharmacol (1978) 2.03
Roles of P2-purinoceptors in the cardiovascular system. Circulation (1991) 2.03
Description of the Genetic Analysis Workshop 11 Collaborative Study on the Genetics of Alcoholism. Genet Epidemiol (1999) 2.01
Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg (1987) 1.99
A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett (1995) 1.99
Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg (1990) 1.99
Large bowel myoelectrical activity in man. Gut (1975) 1.98
Bran tablets and diverticular disease. Br Med J (1976) 1.96
8-phenyltheophylline: a potent P1-purinoceptor antagonist. Eur J Pharmacol (1981) 1.95
Purinergic signalling: pathophysiological roles. Jpn J Pharmacol (1998) 1.94
Research in the training of general surgeons: results of a survey. Ann R Coll Surg Engl (1996) 1.93
The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol Cell Neurosci (1998) 1.92
P2X receptors in peripheral neurons. Prog Neurobiol (2001) 1.91
Potentiation of the effects of exogenously applied ATP and purinergic nerve stimulation on the guinea-pig taenia coli by dipyridamole and hexobendine. Eur J Pharmacol (1972) 1.85
ATP is released from guinea pig ureter epithelium on distension. Am J Physiol Renal Physiol (2002) 1.84
Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate. J Med Chem (1993) 1.84
Cellular studies of sympathetic denervation produced by 6-hydroxydopamine in the vas deferens. J Pharmacol Exp Ther (1970) 1.79
Purinergic receptors. J Theor Biol (1976) 1.79
Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J Cardiovasc Pharmacol (2001) 1.77
Effects of adenosine 5'-triphosphate (ATP) and beta-gamma-methylene ATP on the rat urinary bladder. Br J Pharmacol (1979) 1.76
Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol (1991) 1.75
Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci U S A (1987) 1.74
The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol (1986) 1.72
An analysis of the interactions between sympathetic nerve fibers and smooth muscle cells in tissue culture. Dev Biol (1973) 1.72
P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol (1985) 1.71
Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet (1999) 1.70
PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br J Pharmacol (1993) 1.69
Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflugers Arch (1995) 1.69
Studies on the stereoselectivity of the P2-purinoceptor. Br J Pharmacol (1983) 1.69
Junction potentials at adrenergic synapses. Pharmacol Rev (1966) 1.67
Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet (1989) 1.66
Evolution of the autonomic innervation of visceral and cardiovascular systems in vertebrates. Pharmacol Rev (1969) 1.66
A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation. Br J Pharmacol (1987) 1.65
Atropine-resistant excitatory junction potentials in rabbit bladder are blocked by alpha,beta-methylene ATP. Eur J Pharmacol (1985) 1.63
Comparison of the inhibitory effects on the guinea-pig taenia coli of adenine nucleotides and adenosine in the presence and absence of dipyridamole. Eur J Pharmacol (1975) 1.63
Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels. J Pharmacol Exp Ther (1987) 1.63
GABA may be a neurotransmitter in the vertebrate peripheral nervous system. Nature (1979) 1.61
Breast size and prognosis in early breast cancer. Ann R Coll Surg Engl (1993) 1.59
Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci (1996) 1.58
Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun (1990) 1.58
Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH. Br J Pharmacol (1996) 1.57
An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl. Br J Pharmacol (1970) 1.57
Some patients are happy for doctors to make decisions. BMJ (2000) 1.57
Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor. Br J Pharmacol (1997) 1.57
Molecular cloning and characterization of rat P2Y4 nucleotide receptor. Br J Pharmacol (1998) 1.56
Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg (1991) 1.55
Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut (2004) 1.55
Release of ATP from perfused heart during coronary vasodilatation. Blood Vessels (1974) 1.54
[3H]adenosine triphosphate: release during stimulation of enteric nerves. Science (1971) 1.54
The accuracy of ultrasound in the diagnosis of breast disease. Ann R Coll Surg Engl (1986) 1.54
Antagonism of the effects of purinergic nerve stimulation and exogenously applied ATP on the guinea-pig taenia coli by 2-substituted imidazolines and related compounds. Eur J Pharmacol (1973) 1.54
Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res (1998) 1.53
Neural nomenclature. Nature (1971) 1.52
Actions mediated by P2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat. Br J Pharmacol (1988) 1.52
Dual adrenergic and cholinergic innervation of the cerebral arteries of the rat. An ultrastructural study. Circ Res (1970) 1.52
Mortality in a university surgical unit: what is an avoidable death? J R Soc Med (1991) 1.51
Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol (2004) 1.50